Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy

Neurology

Volumn 54, Issue 6, 2000, Pages 1246-1252

  Kilo, Sonja ^a   Berghoff, Martin ^a   Hilz, Max ^c   Freeman, Roy ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c NONE

Author keywords

Axon reflex; Diabetic neuropathy; Endothelium; Nitric oxide

Indexed keywords

ACETYLCHOLINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEUROPATHY; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; NERVE FIBER C; NEUROMODULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SKIN BLOOD FLOW; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0034724256     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.6.1246     Document Type: Article

References (50)

1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:
2. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najarian JS Effects of pancreatic transplantation on diabetic neuropathy [see comments]. N Engl J Med 1990;322:1031-1037.
3. Giannini C, Dyck PJ. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 1995;37:498-504.
4. Feldman EL, Stevens MJ, Greene DA. Pathogenesis of diabetic neuropathy. Clin Neurosci 1997;4:365-370.
5. Brownlee M Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992;15:1835-1843. Review.
6. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997;46(suppl 2):S38-S42.
7. Stevens MJ, Dananberg J, Feldman EL, et al. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 1994;94:853-859.
8. Kihara M, Low PA. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp Neurol 1995;132:180-185.
9. Wardell K, Naver HK, Nilsson GE, Wallin BG. The cutaneous vascular axon reflex in humans characterized by laser Doppler perfusion imaging. J Physiol (Lond) 1993;460:185-199.
10. Theriault M, Dort J, Sutherland G, Zochodne DW. Local human sural nerve blood flow in diabetic and other polyneuropathies. Brain 1997;120(pt 7):1131-1138.
11. Veves A, Akbari CM, Primavera J, et al. Endothehal dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457-463.
12. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 1980;288(5789):373-376.
13. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-142.
14. Rubanyi GM. Endothelium-derived relaxing and contracting factors. J Cell Biochem 1991;46:27-36.
15. Pieper GM, Peltier BA. Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J Cardiovasc Pharmacol 1995;25:397-403.
16. Meraji S, Jayakody L, Senaratne MP, Thomson AB, Kappagoda T. Endothelium-dependent relaxation in aorta of BB rat. Diabetes 1987;36:978-981.
17. Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 1992;35:1011-1019.
18. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90:2548-2554.
19. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-2516.
20. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:771-776.
21. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567-574.
22. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250(5 Pt 2):H822-H827.
23. Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992;263(2 Pt 2):H321-H326.
24. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991;87:432-438.
25. Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995;38:1337-1344.
26. Pitei DL Watkins PJ, Edmonds ME. NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy. Diabet Med 1997;14:284-290.
27. Cameron NE, Cotter MA, Low PA. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 1991;261:E1-E8.
28. Tuck RR, Schmelzer JD, Low PA. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984;107:935-950.
29. Zochodne DW, Ho LT. Normal blood flow but lower oxygen tension in diabetes of young rats: microenvironment and the influence of sympathectomy. Can J Physiol Pharmacol 1992; 70:651-659.
30. Tomlinson DR, Dewhurst M, Stevens EJ, Omawari N, Carrington AL, Vo PA. Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase. Diabet Med 1998;15:579-585.
31. Ward KK Low PA, Schmelzer JD, Zochodne DW. Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 1989;112:197-208.
32. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990;85: 929-932.
33. Kihara M, Low PA. Regulation of rat nerve blood flow: role of epineurial alpha-receptors. J Physiol 1990;422:145-152
34. Zochodne DW, Low PA. Adrenergic control of nerve blood flow. Exp Neurol 1990;109:300-307.
35. Cohen RA, Tesfamariam B, Weisbrod RM, Zitnay KM. Adrenergic denervation in rabbits with diabetes mellitus. Am J Physiol 1990;259(1 Pt 2):H55-H61.
36. Zochodne DW, Cheng C, Sun H. Diabetes increases sciatic nerve susceptibility to endothelin-induced ischemia. Diabetes 1996;45:627-632.
37. Luscher TF, Yang Z. Calcium antagonists and ACE inhibitors: effect on endothelium and vascular smooth muscle. Drugs 1993;46(suppl 2):121-132.
38. Wenzel RR, Duthiers N, Noll G, Bucher J, Kaufmann U, Luscher TF. Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease. Circulation 1996;94:316-322.
39. Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med 1988;318:1306-1309.
40. Benarroch EE Low PA. The acetylchohne-induced flare respouse in evaluation of small fiber dysfunction. Ann Neurol 1991;29:590-595.
41. Low PA, Caskey PE, Tuck RR, Fealey RD, Dyck PJ. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983;14:573-580.
42. Low PA, Zimmerman BR, Dyck PJ. Comparison of distal sympathetic with vagal function in diabetic neuropathy. Muscle Nerve 1986;9:592-596.
43. Zimmet PZ. The pathogenesis and prevention of diabetes in adults: Genes, autoimmunity, and demography. Diabetes Care 1995;18:1050-1064.
44. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994;331:1428-1436.
45. Porte D Jr Halter JB. The clinical syndrome of diabetic neuropathy. In: Dyck PJ, Thomas PK, eds. Diabetic neuropathy. Philadelphia: WB Saunders, 1999:1-28.
46. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-486.
47. Jaap AJ Tooke JE. Pathophysiology of microvascular disease in non-insulin-dependent diabetes. Clin Sci (Colch) 1995;89: 3-12. Editorial.
48. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency [see comments]. Arch Neurol 1998;55: 1513-1520.
49. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996;47:1042-1048.
50. Holland NR, Crawford TO, Hauer P, et al. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998;44:47-59.